Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

236
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
236
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

210
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
210
Altered States of Awareness01:06

Altered States of Awareness

311
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
311
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

271
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
271
Group Polarization01:01

Group Polarization

34.5K
Group polarization is the strengthening of an original group attitude following the discussion of views within a group (Teger & Pruitt, 1967). That is, if a group initially favors a viewpoint, after discussion the group consensus is likely a stronger endorsement of the viewpoint. Conversely, if the group was initially opposed to a viewpoint, group discussion would likely lead to stronger opposition.
34.5K
Social Facilitation01:04

Social Facilitation

32.1K
Not all intergroup interactions lead to negative outcomes. Sometimes, being in a group situation can improve performance. Social facilitation occurs when an individual performs better when an audience is watching than when the individual performs the behavior alone. This typically occurs when people are performing a task for which they are skilled.
32.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tutorial Drug-Drug Interactions.

Clinical and translational science·2025
Same author

The Persistent Ambiguity of Adverse Drug Reactions.

Clinical pharmacology and therapeutics·2025
Same author

Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?

Clinical pharmacology in drug development·2024
Same author

Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.

Frontiers in pharmacology·2021
Same author

5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors as potential targets for the treatment of nicotine use and dependence.

Progress in brain research·2021
Same author

Identification of Optimal Measures of Human Abuse Potential: A Post Hoc Assessment of 19 Studies.

Journal of clinical psychopharmacology·2020

Related Experiment Video

Updated: Aug 12, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K

Psychedelics: Science sabotaged by Social Media.

Edward M Sellers1, Myroslava K Romach2

  • 1, Department of Pharmacology & Toxicology, Medicine and Psychiatry, University of Toronto, Toronto, ON, M5S 4K2, Canada; DL Global Partners Inc., 78 Baby Point Crescent, Toronto, ON, M6S 2C1, Canada.

Neuropharmacology
|January 24, 2023
PubMed
Summary

Microdosing psychedelics may offer a viable regulatory pathway for mental disorder treatments. This approach could be more cost-effective and accessible than high-dose therapies, potentially improving patient access to new medication options.

More Related Videos

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K
Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

5.2K

Related Experiment Videos

Last Updated: Aug 12, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.3K
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K
Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

5.2K

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Mental Health Treatment

Background:

  • High and low dose psychedelic drug development faces significant regulatory hurdles.
  • Misinformation regarding psychedelic efficacy and safety persists among the public and professionals.

Purpose of the Study:

  • To explore the potential of psychedelic microdosing as a viable alternative to high-dose psychedelic therapy.
  • To assess the feasibility of microdosing for regulatory approval and integration into standard mental health treatment models.

Main Methods:

  • Review of existing scientific literature on psychedelic drug development challenges.
  • Analysis of regulatory pathways for psychotherapeutic agents versus high-dose psychedelic treatments.
  • Discussion of potential therapeutic roles for both microdose and high-dose psychedelic agents.

Main Results:

  • Psychedelic microdosing may circumvent many scientific and regulatory challenges associated with high-dose psychedelics.
  • A microdosing model could align with standard outpatient treatment, offering cost-effectiveness and broader accessibility.
  • Microdosing may avoid the stringent Risk Evaluation and Mitigation Strategies required for high-dose psychedelic therapies.

Conclusions:

  • Psychedelic microdosing presents a promising avenue for developing new mental health treatments.
  • Further research into the efficacy and long-term safety of microdosing is warranted.
  • Microdosing could significantly expand treatment options for individuals with mental disorders.